Journal of General Virology, Vol 79, 1945-1950, Copyright © 1998 by Society for General Microbiology

ARTICLES

The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis

M Nascimbeni, M Bouyac, F Rey, B Spire and F Clavel
CNRS URA 1157, Departement Sida et Retrovirus, Institut Pasteur, Paris, France. micky@bichat.inser.fr

The Vif protein of human immunodeficiency virus type 1 (HIV-1) is essential for the infectivity of virions produced by non-permissive cells. The primary replicative defect of Vif particles involves either synthesis or stability of viral DNA, but the mechanism of this defect is unknown. Here, we report the results of a detailed analysis of HIV-1 DNA synthesis by isogenic Vif- mutants produced by different chronically infected H9 clones, which exhibit different degrees of impairment in their replicative capacity. We found that the degree of impairment of DNA synthesis by the mutant particles always correlated with the degree of their loss of infectivity. This impairment appears to be global, with a defect increasing along with synthesis of longer viral DNA species. We conclude that the primary replicative defect of Vif- virus involves the capacity of the reverse transcription complex of HIV-1 to efficiently elongate viral DNA, resulting in an inability to produce full-length viral DNA genomes.

This article has been cited by other articles:

				S. Henriet, L. Sinck, G. Bec, R. J. Gorelick, R. Marquet, and J.-C. Paillart Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription Nucleic Acids Res., August 1, 2007; 35(15): 5141 - 5153. [Abstract] [Full Text] [PDF]

				A. C. Ribeiro, A. Maia e Silva, M. Santa-Marta, A. Pombo, J. Moniz-Pereira, J. Goncalves, and I. Barahona Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G J. Virol., January 15, 2005; 79(2): 823 - 833. [Abstract] [Full Text] [PDF]

				B. Liu, X. Yu, K. Luo, Y. Yu, and X.-F. Yu Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G J. Virol., February 15, 2004; 78(4): 2072 - 2081. [Abstract] [Full Text] [PDF]

				N. C. Gaddis, E. Chertova, A. M. Sheehy, L. E. Henderson, and M. H. Malim Comprehensive Investigation of the Molecular Defect in vif-Deficient Human Immunodeficiency Virus Type 1 Virions J. Virol., May 15, 2003; 77(10): 5810 - 5820. [Abstract] [Full Text] [PDF]

				S. Kao, H. Akari, M. A. Khan, M. Dettenhofer, X.-F. Yu, and K. Strebel Human Immunodeficiency Virus Type 1 Vif Is Efficiently Packaged into Virions during Productive but Not Chronic Infection J. Virol., December 20, 2002; 77(2): 1131 - 1140. [Abstract] [Full Text] [PDF]

				M. A. Khan, C. Aberham, S. Kao, H. Akari, R. Gorelick, S. Bour, and K. Strebel Human Immunodeficiency Virus Type 1 Vif Protein Is Packaged into the Nucleoprotein Complex through an Interaction with Viral Genomic RNA J. Virol., August 15, 2001; 75(16): 7252 - 7265. [Abstract] [Full Text] [PDF]

				C. W. Hooker, W. B. Lott, and D. Harrich Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Target Distinct Phases of Early Reverse Transcription J. Virol., April 1, 2001; 75(7): 3095 - 3104. [Abstract] [Full Text]

				A. Öhagen and D. Gabuzda Role of Vif in Stability of the Human Immunodeficiency Virus Type 1 Core J. Virol., December 1, 2000; 74(23): 11055 - 11066. [Abstract] [Full Text]

				M. Dettenhofer, S. Cen, B. A. Carlson, L. Kleiman, and X.-F. Yu Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription J. Virol., October 1, 2000; 74(19): 8938 - 8945. [Abstract] [Full Text]